Over the past several years, there has been an increasing interest in the use of nanoparticles as a tool for treatment of cancer. We have shown tremendous augmentation and control (without toxicity) of both heat and cold-based thermal therapy for cancer treatment with a gold based nanodrug-CYT-6091 (Cytimmune Sciences, Inc.) [1–3]. To reach the full potential of these nanodrugs for both stand-alone solid cancer treatment and as adjuvant to thermal therapy, there is a need to understand the in vivo biodistribution and their short-term and long-term tissue interaction.
- Bioengineering Division
Biodistribution of TNF-alpha Coated Gold Nanoparticles in an In Vivo Cancer Model
- Views Icon Views
- Share Icon Share
- Search Site
Goel, R, Shah, N, Visaria, R, Paciotti, GF, & Bischof, JC. "Biodistribution of TNF-alpha Coated Gold Nanoparticles in an In Vivo Cancer Model." Proceedings of the ASME 2008 Summer Bioengineering Conference. ASME 2008 Summer Bioengineering Conference, Parts A and B. Marco Island, Florida, USA. June 25–29, 2008. pp. 831-832. ASME. https://doi.org/10.1115/SBC2008-192931
Download citation file: